WCPS: Analysis of Metal Impurities in Pharmaceutical Ingredients in Preparation for the New USP Methods
Posters
| 2011 | Agilent Technologies
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
WCPS: Validating ICP-MS Using USP<232>/<233> for Elemental Impurity Analysis in Pharmaceutical Products
Posters
| 2012 | Agilent Technologies
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Elemental Impurities in Aspirin: USP <232>/<233> and ICH Q3D Methods Using ICP-OES
Applications
| 2021 | Agilent Technologies
ICP/OES
Instrumentation
ICP/OES
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Validating performance of an Agilent ICP‑MS for USP <232>/<233> & ICH Q3D(R2)/Q2(R1)
Applications
| 2022 | Agilent Technologies
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Validating the Agilent 7700x/7800 ICP-MS for the determination of elemental impurities in pharmaceutical ingredients according to draft USP general chapters <232>/<233>
Applications
| 2015 | Agilent Technologies
ICP/MS
Instrumentation
ICP/MS
Manufacturer
Agilent Technologies
Industries
Proposed new ICH and USP methods for elemental impurities: The application of ICP-MS and ICP-OES for pharmaceutical analysis
Technical notes
| 2014 | Agilent Technologies
ICP/MS, ICP/OES
Instrumentation
ICP/MS, ICP/OES
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma
Prev
1
Next
Related content
Surface-mounted regular arrays of fullerene-based molecular rotors
Th, 28.3.2024
Ústav organické chemie a biochemie AV ČR
Science is made by people and people are driven by passion. However, passion alone is not enough, says Vinicius Santana